These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4126721)

  • 21. The evolution of the radiotherapeutic concept in Hodgkin's disease.
    Peters MV
    Ser Haematol; 1973; 6(2):117-38. PubMed ID: 4593778
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
    J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy.
    Lacher MJ
    Prog Clin Cancer; 1982; 8():283-97. PubMed ID: 7156405
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival and relapse data in Hodgkin's disease: Freiburg im Breisgau, 1948-69.
    Musshoff K
    Natl Cancer Inst Monogr; 1973 May; 36():531-9. PubMed ID: 4744608
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of Hodgkin's disease.
    Rosenberg SA
    N Engl J Med; 1978 Nov; 299(22):1246-7. PubMed ID: 714082
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical procedures for evaluating survival in Hodgkin's disease.
    Myers MH; Axtell LM
    Natl Cancer Inst Monogr; 1973 May; 36():555-9. PubMed ID: 4800297
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 29. Hodgkin's disease. Results of treatment.
    Jelliffe AM
    Proc R Soc Med; 1972 Dec; 65(12):1113-5. PubMed ID: 4651398
    [No Abstract]   [Full Text] [Related]  

  • 30. Laparotomy in the re-evaluation of patients with advanced Hodgkin's disease.
    Kostraba NC; Peterson BA; Kennedy BJ; Grage TB; Bloomfield CD
    Cancer Treat Rep; 1981; 65(7-8):685-7. PubMed ID: 7248986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is it necessary to combine radiotherapy with chemotherapy in the treatment of children and adults with non-advanced Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1979 Feb; 34(9):349-51. PubMed ID: 432142
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ; Andrieu JM
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late relapse after treatment for clinical stage I and II Hodgkin's disease.
    Brierley JD; Rathmell AJ; Gospodarowicz MK; Sutcliffe SB; Pintillie M
    Cancer; 1997 Apr; 79(7):1422-7. PubMed ID: 9083165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Curableness of Hodgkin's disease].
    Glińska H
    Folia Med Cracov; 1971; 13(4):445-500. PubMed ID: 5139805
    [No Abstract]   [Full Text] [Related]  

  • 35. International Symposium on Hodgkin's Disease. Session 6. Survival data and prognosis. Criteria of cure: clinical-pathological correlations.
    Rappaport H; Strum SB
    Natl Cancer Inst Monogr; 1973 May; 36():567-9. PubMed ID: 4744611
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary management of Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1968 Jan; 278(2):93-5. PubMed ID: 4863778
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of the 3d phase of lymphography in the assessment of the effectiveness of treatment of Hodgkin's disease].
    Dergachev AI
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):12-5. PubMed ID: 523445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of clinical stages I and II of Hodgkin's disease].
    Tubiana M; Mathé G; Hayat M; le Bourgeois JP; Henry-Amar M; Laugier A
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):463-72. PubMed ID: 917835
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognosis in Hodgkin's disease with special reference to histologic type. Results of treatment predominantly by cytostatics.
    Andersen AP; Brincker H; Lass F
    Acta Radiol Ther Phys Biol; 1970 Apr; 9(2):81-101. PubMed ID: 4192443
    [No Abstract]   [Full Text] [Related]  

  • 40. Hodgkin's disease: considerable progress and more to be achieved.
    Mathé G; Tubiana M
    Ser Haematol; 1973; 6(2):244-69. PubMed ID: 4361523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.